roflumilast 0.5 MG Oral Tablet [Daliresp]

RxCUI: 1091843
RxNorm name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Display name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Full name: roflumilast 0.5 MG Oral Tablet [Daliresp]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Daliresp	ROFLUMILAST	AstraZeneca Pharmaceuticals LP	c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	2020-03-12	Warnings, Adverse reactions	Exact identifier rxcui: 1091843

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c9a1d0a8-581f-4f91-a2b8-f419192d0ebf	Daliresp 500 MCG Oral Tablet [PSN] · roflumilast 0.5 MG Oral Tablet [Daliresp] [SBD] · Daliresp 0.5 MG Oral Tablet [SY] · Daliresp 500 MCG Oral Tablet [SY]	4	15	These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011	20200312